SYNRIBO (Cephalon, Inc.)
Welcome to the PulseAid listing for the SYNRIBO drug offered from Cephalon, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cephalon, Inc. |
| NON-PROPRIETARY NAME: | Omacetaxine Mepesuccinate |
| SUBSTANCE NAME: | OMACETAXINE MEPESUCCINATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-11-19 |
| END MARKETING DATE: | 0000-00-00 |
SYNRIBO HUMAN PRESCRIPTION DRUG Details:
| Item Description | SYNRIBO from Cephalon, Inc. |
| LABELER NAME: | Cephalon, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.5(mg/mL) |
| START MARKETING DATE: | 2012-11-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63459-177_ac6c18d2-3fea-42f8-8ce7-20019b6c622e |
| PRODUCT NDC: | 63459-177 |
| APPLICATION NUMBER: | NDA203585 |
Other OMACETAXINE MEPESUCCINATE Pharmaceutical Manufacturers / Labelers:
